REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma

Autor: Caccese, M., Desideri, I., Villani, V., Simonelli, M., Buglione, M., Chiesa, S., Franceschi, E., Gaviani, P., Stasi, I., Caserta, C., Brugnara, S., Lolli, I., Bennicelli, E., Bini, P., Cuccu, A.S., Scoccianti, S., Padovan, M., Gori, S., Bonetti, A., Giordano, P., Pellerino, A., Gregucci, F., Riva, N., Cinieri, S., Internò, V., Santoni, M., Pernice, G., Dealis, C., Stievano, L., Paiar, F., Magni, G., De Salvo, G.L., Zagonel, V., Lombardi, G.

Publikováno v: In ESMO Open April 2024 9(4)

An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study

Autor: Internò, V., Massari, F., Rudà, R., Maiorano, B.A., Caffo, O., Procopio, G., Bracarda, S., Atzori, F., Passarelli, A., Bersanelli, M., Stellato, M., Fornarini, G., Galli, L., Ortega, C., Zanardi, E., Incorvaia, L., Facchini, G., Giron Berrios, J.R., Ricotta, R., Santoni, M., Funaioli, C., Trerotoli, P., Porta, C., Rizzo, M.

Publikováno v: In ESMO Open August 2023 8(4)

Reirradiation with radiosurgery or stereotactic fractionated radiotherapy in association with regorafenib in recurrent glioblastoma.

Autor: Gregucci F; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy. fabianagregucci@gmail.com., Di Guglielmo FC; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Surgo A; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Carbonara R; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Laera L; Department of Medical Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Ciliberti MP; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Gentile MA; Department of Radiology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Calbi R; Department of Radiology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Caliandro M; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Sasso N; Department of Medical Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Davi' V; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Bonaparte I; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Fanelli V; Department of Neurosurgery, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Giraldi D; Department of Neurosurgery, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Tortora R; Centro Orientamento Oncologico (COrO), Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Internò V; Department of Medical Oncology, Ospedale San Paolo, Bari, Italy., Giuliani F; Department of Medical Oncology, Ospedale San Paolo, Bari, Italy., Surico G; Department of Medical Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy., Signorelli F; Division of Neurosurgery, Department of Translational Biomedicine and Neurosciences (DiBraiN), University 'Aldo Moro' of Bari, Bari, Italy., Lombardi G; Department of Medical Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Fiorentino A; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti-Bari, Italy.; Department of Medicine and Surgery, LUM University, Casamassima-Bari, Italy.

Publikováno v: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2024 Sep; Vol. 200 (9), pp. 751-759. Date of Electronic Publication: 2023 Nov 21.

Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities.

Autor: Maccari M; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Baek C; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, DMU Neurosciences, Service de Neurologie 2-Mazarin, Paris, France., Caccese M; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Mandruzzato S; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.; Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy., Fiorentino A; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti, Bari, Italy.; Department of Medicine and Surgery, LUM University, Casamassima, Bari, Italy., Internò V; Oncology Unit, San Paolo Hospital, Bari, Italy., Bosio A; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Cerretti G; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Padovan M; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Idbaih A; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, DMU Neurosciences, Service de Neurologie 2-Mazarin, Paris, France., Lombardi G; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.

Publikováno v: The oncologist [Oncologist] 2024 Apr 04; Vol. 29 (4), pp. 289-302.

Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies.

Autor: Internò V; Department of Interdisciplinary Medicine, University of Bari Aldo Moro, 70121 Bari, Italy.; Medical Oncology Unit, Azienda Ospedaliero-Universitaria, Policlinico di Bari, 70124 Bari, Italy., Sergi MC; Medical Oncology Unit, Azienda Ospedaliero-Universitaria, Policlinico di Bari, 70124 Bari, Italy., Metta ME; Medical Statistic and Biometry Unit, Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, 70121 Bari, Italy., Guida M; IRCCS, Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., Trerotoli P; Medical Statistic and Biometry Unit, Department of Interdisciplinary Medicine, University of Bari Aldo Moro, 70124 Bari, Italy., Strippoli S; IRCCS, Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., Circelli S; Medical Oncology Unit, Azienda Ospedaliero-Universitaria, Policlinico di Bari, 70124 Bari, Italy., Porta C; Department of Interdisciplinary Medicine, University of Bari Aldo Moro, 70121 Bari, Italy.; Medical Oncology Unit, Azienda Ospedaliero-Universitaria, Policlinico di Bari, 70124 Bari, Italy., Tucci M; Department of Interdisciplinary Medicine, University of Bari Aldo Moro, 70121 Bari, Italy.; Medical Oncology Unit, Azienda Ospedaliero-Universitaria, Policlinico di Bari, 70124 Bari, Italy.

Publikováno v: Cancers [Cancers (Basel)] 2023 Feb 28; Vol. 15 (5). Date of Electronic Publication: 2023 Feb 28.